Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/SPEXIS-AG-43371335/news/Basilea-kauft-praklinisches-Antibiotika-Programm-von-Spexis-fur-bis-zu-2-Mio-Fr-45738485/?utm_source=whatsapp&utm_medium=social&utm_campaign=share